The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma - Concepedia

Concepedia

Publication | Closed Access

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma

53

Citations

0

References

1998

Year

M Moos, R. J. Schulz, Sylvia Martin, Axel Benner, Rainer Haas

Hematological MalignancyPcr StatusLymphoid NeoplasiaMedicineImmunologyHematologyPathologyRelapse-free SurvivalRemission StatusOncologyCancer Research

No additional data available for this publication yet. Check back later!